CapitolRadar tracks every publicly disclosed PFE trade by US congress members and corporate insiders: 94 disclosed trades (53 buys, 41 sells) by 6 tracked traders, from 2020-02-11 to 2026-09-25. Updated daily from official filings.
🔥 In the news right now: PFE picked up 34 news headlines in the last 48 hours. Attention is not evidence. It tells you what people are looking at, not whether they are right.
Want a ping when Congress buys PFE? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
Pfizer Inc. (PFE) — Healthcare · Drug Manufacturers - General, market cap about $167.1B.
CapitolRadar analysis
2 PFE trades split evenly between buys and sells
2 tracked trades in Pfizer Inc. (PFE) span March 10, 2025, through July 7, 2026. The activity consists of 1 buy and 1 sell by 2 distinct traders. That even split does not establish a directional pattern, particularly because the sample contains only two transactions.
1 trade occurred in 2025 Q1, and it was a sale. The other trade appeared in 2026 Q3 and was a purchase. With the transactions separated across different quarters and attributed to different traders, the record shows isolated activity rather than repeated buying or selling by the same person.
1 disclosed buyer: Ro Khanna
1 PFE purchase is attributed to Ro Khanna, with the latest buy dated July 7, 2026. The supplied data identifies no additional PFE buyers and does not name the trader responsible for the March 10, 2025 sale. As a result, comparisons between the buyer and seller are not possible from this record.
6 other tickers were also purchased by the identified PFE buyer: ServiceNow (NOW), Ingersoll Rand (IR), Fortive (FTV), Ares Management (ARES), PACCAR (PCAR), and Meta Platforms (META). Each overlap represents the same single buyer, so these co-purchases should not be interpreted as a pattern shared by multiple PFE buyers.
Small sample and disclosure timing limit the signal
45 days may pass before a congressional transaction is disclosed, meaning reported activity can appear well after the underlying trade. Disclosed transaction values are generally presented as amount ranges, which are estimates rather than exact trade sizes; no transaction-size ranges are included in the supplied PFE facts. The combination of delayed reporting, missing size information, and a two-trade sample materially limits conclusions about trading intensity or broader sentiment toward Pfizer, a Healthcare company in the Drug Manufacturers - General industry.
Analysis written from the tracked record on 2026-08-24; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q3 | 4 | 3 | 1 |
| 2026 Q2 | 2 | 1 | 1 |
| 2026 Q1 | 1 | 0 | 1 |
| 2025 Q3 | 2 | 0 | 2 |
| 2025 Q2 | 1 | 0 | 1 |
| 2025 Q1 | 1 | 0 | 1 |
| 2024 Q4 | 1 | 1 | 0 |
| 2024 Q2 | 1 | 0 | 1 |
Who is buying PFE?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Ro Khanna | 37 | 2026-09-25 | — |
| Lois Frankel | 12 | 2023-06-28 | — |
| Tommy Tuberville | 4 | 2024-02-27 | — |
Disclosed trades in PFE
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-09-11 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-09-04 | Ro Khanna | sell | $15,001 - $50,000 | — |
| 2026-07-07 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-06-08 | Tommy Tuberville | sell | $15,001 - $50,000 | — |
| 2026-04-13 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-01-29 | Ro Khanna | sell | $15,001 - $50,000 | — |
| 2025-09-15 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2025-09-05 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2025-06-03 | Josh Gottheimer | sell | $1,001 - $15,000 | — |
| 2025-03-10 | Carol Devine Miller | sell | $15,001 - $50,000 | — |
| 2024-11-13 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2024-05-03 | Tommy Tuberville | sell | $15,001 - $50,000 | — |
| 2024-03-25 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2024-03-20 | Ro Khanna | buy | $15,001 - $50,000 | — |
| 2024-02-27 | Tommy Tuberville | buy | $1,001 - $15,000 | — |
| 2024-02-13 | Ro Khanna | sell | $50,001 - $100,000 | — |
| 2024-02-13 | Ro Khanna | buy | $15,001 - $50,000 | — |
| 2024-01-31 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2024-01-10 | Ro Khanna | sell | $15,001 - $50,000 | — |
CapitolRadar signal history
NEW PICK 2026-10-12
Rep. Ro Khanna disclosed a $1,001–$15,000 purchase of Pfizer stock. The panel’s biggest concern was that the reported trade is future-dated, making the record difficult to validate and the signal unreliable. An official filing confirming a corrected, completed trade date and purchase price would have provided the evidence needed to reconsider the verdict.
These buyers also bought
Other stocks the tracked buyers of PFE disclosed buying in the last six months: ACGL (1) · AMT (1) · BIIB (1) · CCL (1) · COR (1) · DGX (1).
About Pfizer Inc.
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective…
Frequently asked questions
Which politicians bought PFE most?
Ro Khanna leads with 37 disclosed buys, followed by Lois Frankel.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.